Literature DB >> 26064298

Effects of Foxp3 gene modified dendritic cells on mouse corneal allograft rejection.

Yu-Bo Gong1, Lian-Na Hu2, Yong Liu3, Gen-Cheng Han4, Hui-Ling Guo2, Ling Luo2, Li-Qiang Wang5, Yan Li4, Yi-Fei Huang5.   

Abstract

OBJECTIVE: To investigate the effect of Foxp3 gene modified dendritic cells (Foxp3 + DC) on allogeneic T cells proliferation and to study the effect of Foxp3 + DC on corneal allograft rejection.
METHODS: Lentivirus-Foxp3 was transfected into DC2.4 cells, as Foxp3 + DC cells. 42 BALB/c mice were randomly divided into: Group A (n = 6), normal group; Group B (n = 12), Group C (n = 12) and Group D (n = 12), allograft groups, were treated with normal saline, DC2.4, Foxp3 + DC by intraperitoneal injection, respectively.
RESULTS: Compared with the control group, Foxp3 protein in the Foxp3 + DC cells increased significantly (P < 0.05); the expressions of CD80 and CD86 immunophenotypes of Foxp3 + DC cells decreased significantly (P < 0.05); IL-12 secretion reduced (P < 0.05), but IL-10 secretion was promoted (P < 0.05). The average transplant survival time in Group B was (14.833 ± 1.472) d, and Group C and Group D led to a statistically significant prolongation of transplant survival to (17.667 ± 1.366, 23.000 ± 2.000) d (P < 0.05) respectively. 14 d after transplantation, as compared with Group C and D, the expressions of IFN-γ in grafts markedly increased in Group B. 14 d after transplantation, as compared with Group B, the expressions of Foxp3 mRNA, IDO mRNA in grafts decreased remarkably in Group C and D (P < 0.05); as compared with Group C, the expressions of Foxp3 mRNA, IDO mRNA in grafts decreased remarkably in Group D (P < 0.05).
CONCLUSION: Foxp3 + DC cells reduce the expression of costimulatory factors, reduce the secretion of IL-12, promote IL-10 production and inhibit the stimulation of alloreactive T cell proliferation response capacity. Foxp3 + DC cells play important roles in inhibiting corneal allograft immune response and prolonging graft survival time.

Entities:  

Keywords:  DC2.4; Foxp3; corneal transplantation; immune tolerance; lentivirus

Year:  2015        PMID: 26064298      PMCID: PMC4443132     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  29 in total

1.  Hyperexpression of Foxp3 and IDO during acute rejection of islet allografts.

Authors:  Hua Yang; Ruchuang Ding; Vijay K Sharma; Fludd Saint Hilaire; Milagros Lagman; Baogui Li; Dolca A Thomas; Dolea A Thomas; Xunrong Luo; Ping Song; Craig Stauffer; Phyllis August; Manikkam Suthanthiran
Journal:  Transplantation       Date:  2007-06-27       Impact factor: 4.939

2.  Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules.

Authors:  Z Shen; G Reznikoff; G Dranoff; K L Rock
Journal:  J Immunol       Date:  1997-03-15       Impact factor: 5.422

3.  Treatment of corneal transplant rejection in humans with anti-interferon-gamma antibodies.

Authors:  Simon Skurkovich; Alexander Kasparov; Nikolai Narbut; Boris Skurkovich
Journal:  Am J Ophthalmol       Date:  2002-06       Impact factor: 5.258

4.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

5.  Gene delivery of indoleamine 2,3-dioxygenase prolongs cardiac allograft survival by shaping the types of T-cell responses.

Authors:  Guang Yu; Hong Dai; Jie Chen; Lihua Duan; Min Gong; Li Liu; Ping Xiong; Cong-Yi Wang; Min Fang; Feili Gong
Journal:  J Gene Med       Date:  2008-07       Impact factor: 4.565

6.  Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase.

Authors:  David H Munn; Madhav D Sharma; Jeffrey R Lee; Kanchan G Jhaver; Theodore S Johnson; Derin B Keskin; Brendan Marshall; Phillip Chandler; Scott J Antonia; Russell Burgess; Craig L Slingluff; Andrew L Mellor
Journal:  Science       Date:  2002-09-13       Impact factor: 47.728

7.  Indoleamine 2,3-dioxygenase and foxp3 expression in skin rejection of human hand allografts.

Authors:  T Hautz; G Brandacher; B Zelger; H G Müller; A W P Lee; D Fuchs; R Margreiter; S Schneeberger
Journal:  Transplant Proc       Date:  2009-03       Impact factor: 1.066

8.  Treatment of pancreatic cancer with an oncolytic adenovirus expressing interleukin-12 in Syrian hamsters.

Authors:  Sergia Bortolanza; Maria Bunuales; Itziar Otano; Gloria Gonzalez-Aseguinolaza; Carlos Ortiz-de-Solorzano; Daniel Perez; Jesus Prieto; Ruben Hernandez-Alcoceba
Journal:  Mol Ther       Date:  2009-02-17       Impact factor: 11.454

9.  TGF-beta and kynurenines as the key to infectious tolerance.

Authors:  Maria L Belladonna; Ciriana Orabona; Ursula Grohmann; Paolo Puccetti
Journal:  Trends Mol Med       Date:  2009-01-21       Impact factor: 11.951

10.  IDO and regulatory T cell support are critical for cytotoxic T lymphocyte-associated Ag-4 Ig-mediated long-term solid organ allograft survival.

Authors:  Robert Sucher; Klaus Fischler; Rupert Oberhuber; Irmgard Kronberger; Christian Margreiter; Robert Ollinger; Stefan Schneeberger; Dietmar Fuchs; Ernst R Werner; Katrin Watschinger; Bettina Zelger; George Tellides; Nina Pilat; Johann Pratschke; Raimund Margreiter; Thomas Wekerle; Gerald Brandacher
Journal:  J Immunol       Date:  2011-11-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.